Literature DB >> 3471315

Daunomycin accumulation in resistant tumor cells as a screening model for resistance modifying drugs: role of protein binding.

H J Broxterman, C M Kuiper, G J Schuurhuis, J J van der Hoeven, H M Pinedo, J Lankelma.   

Abstract

A potential screening system for drugs that modify anthracycline resistance was investigated. The effect of the calcium antagonistic agents verapamil, diltiazem, bepridil and Ro 11-2933/001 on daunorubicin (DNR) accumulation in the doxorubicin resistant cell line 2780AD was measured. For this purpose cells were suspended in medium with varying concentrations of bovine serum albumin (BSA) and in human plasma to establish the influence of protein binding on DNR accumulation. Increase of protein concentration did not affect DNR accumulation when no calcium antagonists were present but caused an increase in concentrations of calcium antagonists needed to promote DNR accumulation. It appeared that DNR accumulation in suspended cells correlated well with cytotoxicity assays, performed on cells growing in monolayer in 96-well microtiter plates, when accumulation was measured in medium with the same protein constitution as in growth medium (10% fetal calf serum). It is concluded that protein binding effects should be taken into account in the screening of compounds for the circumvention of multidrug resistance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3471315     DOI: 10.1016/0304-3835(87)90060-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  Reversal of multidrug resistance by B859-35, a metabolite of B859-35, niguldipine, verapamil and nitrendipine.

Authors:  J Hofmann; A Wolf; M Spitaler; G Böck; J Drach; C Ludescher; H Grunicke
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  In vitro activity of S 9788 on a multidrug-resistant leukemic cell line and on normal hematopoietic cells-reversal of multidrug resistance by sera from phase I-treated patients.

Authors:  J Soudon; M Berlion; C Lucas; P Haddad; J P Bizzari; F Calvo
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

3.  Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells.

Authors:  H J Broxterman; H M Pinedo; G J Schuurhuis; J Lankelma
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

4.  The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance.

Authors:  G J Schuurhuis; H J Broxterman; H M Pinedo; T H van Heijningen; C K van Kalken; J B Vermorken; E C Spoelstra; J Lankelma
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

5.  Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.

Authors:  R Pieters; T Hongo; A H Loonen; D R Huismans; H J Broxterman; K Hählen; A J Veerman
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.